Biotechnology company developing NeoX™, a small-molecule platform that disrupts bacterial biofilms and disables antimicrobial resistance mechanisms, aiming to restore the effectiveness of existing antibiotics and biocides
Biotechnology company developing NeoX™, a small-molecule platform that disrupts bacterial biofilms and disables antimicrobial resistance mechanisms, aiming to restore the effectiveness of existing antibiotics and biocides. Its lead inhaled candidate has Phase I safety data, with applications across human, animal, plant, marine, and industrial settings.